Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in ERBB2-Positive Breast Cancer
This cross-sectional study assesses whether treatment-induced cardiotoxicity is associated with long-term cardiopulmonary dysfunction in survivors of ERBB2-positive breast cancer.